Polynucleotides have become one of the more discussed actives in modern Korean and clinical skincare. The category sounds futuristic, and in many ways it is. The molecules originate as fragments of DNA, most commonly derived from purified salmon sperm, and they have a real and growing body of clinical research behind them. The topical version is more limited than the injectable version, but the science is moving quickly.
What polynucleotides actually are
Polynucleotides are short chains of nucleotides, the building blocks of DNA. The most studied form in skincare is PDRN, polydeoxyribonucleotide, derived from salmon DNA. Salmon DNA shares a high degree of similarity with human DNA, which is part of why these molecules can interact with human cell receptors.
What PDRN does
Stimulates fibroblast activity, supporting collagen and elastin synthesis.
The strongest evidence for polynucleotides is in injectable form, used in clinical aesthetics for skin density, firmness, and recovery. Topical formulas use stabilized fragments designed for surface and upper-layer delivery. The effect is gentler and more gradual, but still meaningful for routine use.
How to use topical polynucleotides
Apply on clean, slightly damp skin, usually before heavier serums and moisturizers. They pair cleanly with peptides, niacinamide, ceramides, hyaluronic acid, and centella. Most products are designed for daily use over twelve weeks or more.
Improved hydration and bounce within four to eight weeks.
Firmer, more resilient skin over twelve to sixteen weeks.
Refined tone and texture over months.
Subtle effects, not dramatic transformation.
Who benefits most
Mature skin, post-procedure recovery, skin showing density loss, and routines focused on long-term repair. Younger skin can benefit preventively but does not need polynucleotides as a primary active.
What to be cautious about
Topical polynucleotide formulas are still evolving, and quality varies significantly. Choose products from established Korean or clinically informed brands with stated concentrations and clear formulation logic. Injectable polynucleotides are clinician-only and require medical guidance.
The longer view
Polynucleotides represent the next layer of mechanism-driven skincare, building on the foundations laid by peptides and growth factors. The category is still maturing, and the most important thing is consistency over chasing novelty. Skin guided by clinically informed wisdom adopts ingredients like polynucleotides slowly, with attention to formulation quality and the rest of the routine they sit inside.
Quick answer
Where this fits in Orlena's ingredient education system
This article supports Orlena's protocol-first approach: identify the skin state, choose the pathway, then select ingredients and products by role instead of adding unrelated actives.
Best next step: use the related Orlena protocol or Formula Depths glossary to connect this topic with product examples, ingredient roles, and routine order.
